Complementary and integrative medicine intervention in front-line COVID-19 clinicians.

COVID-19 communication complementary therapy

Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
05 Apr 2022
Historique:
received: 18 08 2021
accepted: 08 03 2022
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 7 4 2022
Statut: aheadofprint

Résumé

To assess the impact of a multidisciplinary complementary and integrative medicine (CIM) intervention on physical and emotional concerns among front-line COVID-19 healthcare providers (HCPs). A multimodality CIM treatment intervention was provided by integrative practitioners to HCPs in three isolated COVID-19 departments. HCPs' two main concerns were scored (from 0 to 6) before and following the CIM intervention using the Measure Yourself Concerns and Wellbeing questionnaire. Postintervention narratives identified reflective narratives specifying emotional and/or spiritual keywords. Of 181 HCPs undergoing at least one CIM treatment, 119 (65.7%) completed post-treatment questionnaires. While HCPs listing baseline emotional-related concerns benefited from the CIM intervention, those who did not express emotional or spiritual concerns improved even more significantly following the first session, for both leading concerns (p=0.038) and emotional-related concerns (p=0.023). Nevertheless, it was shown that following subsequent treatments HCPs who expressed emotional and spiritual concerns improved more significantly than those who did not for emotional-related concerns (p=0.017). A CIM intervention for front-line HCPs working in isolated COVID-19 departments can significantly impact emotional-related concerns, more so after the first treatment and among HCPs not using emotional-spiritual keywords in post-treatment narratives. Referral of HCPs to CIM programmes for improved well-being should avoid referral bias to those not expressing emotional/spiritual concerns.

Identifiants

pubmed: 35383045
pii: bmjspcare-2021-003333
doi: 10.1136/bmjspcare-2021-003333
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Eran Ben-Arye (E)

Integrative Oncology Program, The Oncology Service, Lin, Carmel, and Zebulun Medical centers, Clalit Health Services, Haifa, Israel eranben@netvision.net.il.
Ruth and Bruch Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Orit Gressel (O)

Integrative Oncology Program, The Oncology Service, Lin, Carmel, and Zebulun Medical centers, Clalit Health Services, Haifa, Israel.

Noah Samuels (N)

Center for Integrative Complementary Medicine, Shaarei Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Nili Stein (N)

Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.

Arieh Eden (A)

Lady Davis Carmel Medical Center, Haifa, Israel.

Jan Vagedes (J)

Department of Pediatrics, University Hospital Tubingen, Tubingen, Germany.

Sameer Kassem (S)

Department of Internal Medicine, Lady Davis Carmel Medical Center, Haifa, Israel.

Classifications MeSH